The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome
Acute myeloid leukemia (AML) is an aggressive malignancy, which is highly heterogeneous with regard to chemosensitivity and biological features. The AML cell population is organized in a hierarchy that is reflected in the in vitro growth characteristics, with only a minority of cells being able to p...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-01-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2072-6694/11/1/73 |
| _version_ | 1797705742124318720 |
|---|---|
| author | Annette K. Brenner Elise Aasebø Maria Hernandez-Valladares Frode Selheim Frode Berven Ida-Sofie Grønningsæter Sushma Bartaula-Brevik Øystein Bruserud |
| author_facet | Annette K. Brenner Elise Aasebø Maria Hernandez-Valladares Frode Selheim Frode Berven Ida-Sofie Grønningsæter Sushma Bartaula-Brevik Øystein Bruserud |
| author_sort | Annette K. Brenner |
| collection | DOAJ |
| description | Acute myeloid leukemia (AML) is an aggressive malignancy, which is highly heterogeneous with regard to chemosensitivity and biological features. The AML cell population is organized in a hierarchy that is reflected in the in vitro growth characteristics, with only a minority of cells being able to proliferate for more than two weeks. In this study, we investigated the ability of AML stem cells to survive and proliferate in suspension cultures in the presence of exogenous mediators but without supporting non-leukemic cells. We saw that a high number of maintained stem cells (i.e., a large number of clonogenic cells after five weeks of culture) was associated with decreased overall survival for patients receiving intensive chemotherapy; this prognostic impact was also detected in the multivariate/adjusted analysis. Furthermore, the patients with many clonogenic cells presented more frequently with mutations in transcription-related genes, and also showed a higher abundance of proteins involved in transcription at the time of diagnosis. In conclusion, the growth characteristics of the long-term proliferating leukemic stem cells seem to have an independent prognostic impact in human AML, and these characteristics appear to be reflected by the mutational landscape and the proteome of the patients at the time of diagnosis. |
| first_indexed | 2024-03-12T05:41:55Z |
| format | Article |
| id | doaj.art-cdc270a9d99d46dd856642f3cf777acf |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-12T05:41:55Z |
| publishDate | 2019-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-cdc270a9d99d46dd856642f3cf777acf2023-09-03T06:00:13ZengMDPI AGCancers2072-66942019-01-011117310.3390/cancers11010073cancers11010073The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse OutcomeAnnette K. Brenner0Elise Aasebø1Maria Hernandez-Valladares2Frode Selheim3Frode Berven4Ida-Sofie Grønningsæter5Sushma Bartaula-Brevik6Øystein Bruserud7Department of Medicine, Haukeland University Hospital; 5021 Bergen, NorwaSection for Hematology, Department of Clinical Science, University of Bergen, 5020 Bergen, NorwaySection for Hematology, Department of Clinical Science, University of Bergen, 5020 Bergen, NorwayThe Proteomics Unit at the University of Bergen, Department of Biomedicine, University of Bergen, 5020 Bergen, NorwayThe Proteomics Unit at the University of Bergen, Department of Biomedicine, University of Bergen, 5020 Bergen, NorwayDepartment of Medicine, Haukeland University Hospital; 5021 Bergen, NorwaSection for Hematology, Department of Clinical Science, University of Bergen, 5020 Bergen, NorwayDepartment of Medicine, Haukeland University Hospital; 5021 Bergen, NorwaAcute myeloid leukemia (AML) is an aggressive malignancy, which is highly heterogeneous with regard to chemosensitivity and biological features. The AML cell population is organized in a hierarchy that is reflected in the in vitro growth characteristics, with only a minority of cells being able to proliferate for more than two weeks. In this study, we investigated the ability of AML stem cells to survive and proliferate in suspension cultures in the presence of exogenous mediators but without supporting non-leukemic cells. We saw that a high number of maintained stem cells (i.e., a large number of clonogenic cells after five weeks of culture) was associated with decreased overall survival for patients receiving intensive chemotherapy; this prognostic impact was also detected in the multivariate/adjusted analysis. Furthermore, the patients with many clonogenic cells presented more frequently with mutations in transcription-related genes, and also showed a higher abundance of proteins involved in transcription at the time of diagnosis. In conclusion, the growth characteristics of the long-term proliferating leukemic stem cells seem to have an independent prognostic impact in human AML, and these characteristics appear to be reflected by the mutational landscape and the proteome of the patients at the time of diagnosis.http://www.mdpi.com/2072-6694/11/1/73acute myeloid leukemiaclonogenic cellscolony formationcytokinesdifferentiationtranscription |
| spellingShingle | Annette K. Brenner Elise Aasebø Maria Hernandez-Valladares Frode Selheim Frode Berven Ida-Sofie Grønningsæter Sushma Bartaula-Brevik Øystein Bruserud The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome Cancers acute myeloid leukemia clonogenic cells colony formation cytokines differentiation transcription |
| title | The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome |
| title_full | The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome |
| title_fullStr | The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome |
| title_full_unstemmed | The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome |
| title_short | The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome |
| title_sort | capacity of long term in vitro proliferation of acute myeloid leukemia cells supported only by exogenous cytokines is associated with a patient subset with adverse outcome |
| topic | acute myeloid leukemia clonogenic cells colony formation cytokines differentiation transcription |
| url | http://www.mdpi.com/2072-6694/11/1/73 |
| work_keys_str_mv | AT annettekbrenner thecapacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT eliseaasebø thecapacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT mariahernandezvalladares thecapacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT frodeselheim thecapacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT frodeberven thecapacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT idasofiegrønningsæter thecapacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT sushmabartaulabrevik thecapacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT øysteinbruserud thecapacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT annettekbrenner capacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT eliseaasebø capacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT mariahernandezvalladares capacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT frodeselheim capacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT frodeberven capacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT idasofiegrønningsæter capacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT sushmabartaulabrevik capacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome AT øysteinbruserud capacityoflongterminvitroproliferationofacutemyeloidleukemiacellssupportedonlybyexogenouscytokinesisassociatedwithapatientsubsetwithadverseoutcome |